Items where Author is "Knights, AJ"
 | Up a level |
Journal article
MATHIEU, M.G., KNIGHTS, A.J., PAWELEC, G., RILEY, C.L., WERNET, D., LEMONNIER, F.A., STRATEN, P.T., MUELLER, L., REES, R.C. and MCARDLE, S.E., 2007. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy, 56 (12), pp. 1885-1895. ISSN 0340-7004
KNIGHTS, A.J., MCARDLE, S.E., MÜLLER, L., MCCULLOCH, T.A., REES, R.C. and PAWELEC, G., 2004. Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicity. Cancer Cell International, 41 (350). ISSN 1475-2867
KNIGHTS, A.J., ZANIOU, A., REES, R.C., PAWELEC, G. and MULLER, L., 2002. Prediction of an HLA-DR-binding peptide derived from Wilms' tumour 1 protein and demonstration of in vitro immunogenicity of WT1(124-138)-pulsed dendritic cells generated according to an optimised protocol. Cancer Immunology Immunotherapy, 51 (5), pp. 271-281. ISSN 0340-7004
Chapter in book
MUELLER, L., MCARDLE, S.E., DERHOVANESSIAN, E., FLAD, T., KNIGHTS, A.J., REES, R.C. and PAWELEC, G., 2005. Current strategies for the identification of immunogenic epitopes of tumor antigens. In: M.L. DISIS, ed., Immunotherapy of Cancer. Humana Press.
